Chronic Kidney Disease Trial, Recruiting NCT07547098 Sponsor: First Affiliated Hospital of Fujian Medical University Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07547098
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have an inpatient hospital record at the First Affiliated Hospital of Fujian Medical University that can be used to link their data
  • People who have a heart or blood vessel condition, a kidney condition, a metabolic condition (such as diabetes or obesity), or relevant test and lab results that support classification into a combined heart-kidney-metabolic health profile
  • People who are willing to take part and sign a written consent form
  • People who are able to complete an initial health assessment and attend follow-up appointments
  • People who have full decision-making capacity and can understand the study information provided

Who may not be able to join:

  • People who are not willing to sign a written consent form
  • People with a serious mental health condition or significant memory or thinking difficulties that would prevent them from taking part
  • People with an advanced illness where survival is expected to be less than one year
  • People who are likely to be away for more than 6 months in a way that would make follow-up unreliable
  • People who are already taking part in another clinical study that could affect how this study's results are measured
  • People whose records are missing important details needed to link their test results, scans, and health outcomes together

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dajun Chai, First Affiliated Hospital of Fujian Medical University

Phone: 008659187981637

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Fujian Medical University
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
28 February 2031

Where this trial is recruiting

🇨🇳 China

Primary endpoints

First occurrence of a cardiorenal composite endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov